BioSpace News Archive

Acoustic monitoring using special buoys will track and monitor one of the world’s most endangered species as well as other whales that frequent waters off New York and New Jersey

Cytonus Therapeutics Inc. announced that it will be presenting preclinical data for its Cargocyte™ technology platform at the American Society of Gene and Cell Therapy annual meeting April 29 – May 2 in Washington, DC.

Genus Lifesciences, Inc., an innovative specialty pharma company engaged in developing and commercializing generic and branded products, relaunched Yosprala delayed tablets at $33 per 30 days’ supply.

Nearly eight years ago, Chad Gobel founded Gobel Group with one employee and one client. Today, Gobel Group has grown to 30 employees and actively works with more than 200 clients around the world.

IQVIA™ (NYSE: IQV) today announced the expansion of Orchestrated Customer Engagement (OCE), IQVIA Technologies’ innovative commercial ecosystem, with the addition of Orchestrated Analytics for OCE, a powerful and flexible analytics solution that empowers life sciences companies to make smarter decisions by providing increased access to insights.

Advanced Medical Management Solutions, LLC (AMMS) today announced it had earned The Joint Commission’s Gold Seal of Approval® for Ambulatory Health Care Accreditation by demonstrating continuous compliance with its nationally recognized standards.

Respected Industry Veteran Will Oversee Company’s Initiatives to Help Grow the Industry

ProHEALTH Care, the largest independent, physician-run health system in the Northeast, announces a new program, PHamily Circle, a community health and charitable giving initiative rooted in Fundraising, Awareness, and Medicine.

Noted interventional cardiologist Leslie Saxon, MD, professor of medicine and executive director of the USC Center for Body Computing at the Keck School of Medicine of USC will be honored as the 2019 Woman of the Year by THE MUSES of the California Science Center Foundation.

Conformal Medical, Inc., developer of the Conformal Left Atrial Appendage Seal for LAA occlusion, reports the first human use of its proprietary technology for the prevention of stroke in patients with atrial fibrillation (AFib).